TY - JOUR
T1 - Comparison of the gyro C1E3 and BioMedicus centrifugal pump performances during cardiopulmonary bypass
AU - Nakazawa, Tadashi
AU - Takami, Yoshiyuki
AU - Makinouchi, Kenzo
AU - Gay, Joseph
AU - Taylor, Deborah
AU - Ueyama, Keishi
AU - Ohashi, Yukio
AU - Kawahito, Koji
AU - Tayama, Eiki
AU - Glueck, Julie
AU - Nosé, Yukihiko
PY - 1997
Y1 - 1997
N2 - The compact eccentric inlet port (C1E3) centrifugal blood pump was developed as a cardiopulmonary bypass (CPB) pump. The C1E3 pump incorporated a seal-less design with a blood stagnation free structure. The pump impeller was magnetically coupled to the driver magnet in a seal-less manner. To develop an atraumatic and antithrombogenic centrifugal pump without a shaft seal junction, a double pivot bearing system was introduced. Recently, a mass production model of the C1E3 was fabricated and evaluated. The ratio of the normalized index of hemolysis (NIH) of the C1E3 was 0.007 g/100 L, in comparison to the NIH of the BP-80, 0.018 g/100 L, each in a CPB condition of 5 L/rain against 325 mm Hg. Both pumps were compared in identical in vitro circuits. To further evaluate the pumps during cardiopulmonary bypass for reliability and function, 6 h of CPB was performed on each of S bovines using either the C1E3 or BP-80 centrifugal pump. The BP-80 and C1E3 provided pump flows of 50-60 ml/kg/min without incident. The hemodynamics were stable, and the hematology and biochemistry data were within normal ranges. There were no statistically significant differences between the 2 groups. Concerning the plasma free hemoglobin values, a mass production model of the C1E3 pump had the same hemolysis levels as the BP-80. Our preliminary studies reveal that the C1E3 pump is reliable. Also, the C1E3 will satisfy clinical requirements as a cardiopulmonary bypass pump.
AB - The compact eccentric inlet port (C1E3) centrifugal blood pump was developed as a cardiopulmonary bypass (CPB) pump. The C1E3 pump incorporated a seal-less design with a blood stagnation free structure. The pump impeller was magnetically coupled to the driver magnet in a seal-less manner. To develop an atraumatic and antithrombogenic centrifugal pump without a shaft seal junction, a double pivot bearing system was introduced. Recently, a mass production model of the C1E3 was fabricated and evaluated. The ratio of the normalized index of hemolysis (NIH) of the C1E3 was 0.007 g/100 L, in comparison to the NIH of the BP-80, 0.018 g/100 L, each in a CPB condition of 5 L/rain against 325 mm Hg. Both pumps were compared in identical in vitro circuits. To further evaluate the pumps during cardiopulmonary bypass for reliability and function, 6 h of CPB was performed on each of S bovines using either the C1E3 or BP-80 centrifugal pump. The BP-80 and C1E3 provided pump flows of 50-60 ml/kg/min without incident. The hemodynamics were stable, and the hematology and biochemistry data were within normal ranges. There were no statistically significant differences between the 2 groups. Concerning the plasma free hemoglobin values, a mass production model of the C1E3 pump had the same hemolysis levels as the BP-80. Our preliminary studies reveal that the C1E3 pump is reliable. Also, the C1E3 will satisfy clinical requirements as a cardiopulmonary bypass pump.
UR - http://www.scopus.com/inward/record.url?scp=8544226959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8544226959&partnerID=8YFLogxK
U2 - 10.1111/j.1525-1594.1997.tb03742.x
DO - 10.1111/j.1525-1594.1997.tb03742.x
M3 - Article
C2 - 9212958
AN - SCOPUS:8544226959
SN - 0160-564X
VL - 21
SP - 782
EP - 785
JO - Artificial Organs
JF - Artificial Organs
IS - 7
ER -